Slide 1Measuring Angiogenesis in Hematologic Diseases Maher Albitar, MD Quest Diagnostics, Nichols Institute San Juan Capistrano, CA 92690 (949)728-4784 [email protected]…

Slide 1Progress Against Leukemia Slide 2 1970–1979 Slide 3 Progress Against Leukemia 1970–1979 1974: FDA approves doxorubicin Slide 4 Progress Against Leukemia 1970–1979…

Slide 1Molecular Pathogenesis of Leukemia PML/RAR  MLL translocations PLZF/RAR  etc. AML1/ETO CBF  /SMMHC TEL/AML1 Other transloc. BCR-ABL Flt3 ITD or mutation…

Slide 1MDS: Classification and Advances in Therapy BTG2013 S. Varma PGIMER, Chandigarh India Slide 2 MDS Highly heterogeneous group of disorders ▫ Variable natural history…

Slide 1 Slide 2 EHA highlights News in MDS JULY31, TYR,LEBANON MARCEL MASSOUD, M.D. Slide 3 MDSs in 2010 EHA 1 education session : 1.THE BIOLOGICAL BASIS OF MYELODYSPLASTIC…

Slide 1 Myelodysplastic, Myeloproliferative, and Histiocytic Disorders Kenneth McClain M.D. Ph.D. Texas Children’s Cancer Center Houston, TX Slide 2 Disclosure Information…

Slide 1 Gba and Zor Joint Communities Forest Management Body Inc. (JCFMB) Mining Concessions and Community Forestry Saye Thompson Chairman JCFMB Slide 2 Brief Introduction…

Slide 1Cancers of the Bone Marrow: A Clinical Perspective Mary Ward, RN, BS, CTR Slide 2 Objectives To increase the Cancer Registrar’s knowledge of the disease process…

Slide 1Computational Identification of Tumor heterogeneity 2015-03-25 Sangwoo Kim Slide 2 Tumor heterogeneity Inter-tumor heterogeneity: genetic and phenotypic variation…

Slide 1 Leukemias Slide 2 Etiology of Leukemias General outlines Acute leukemias Single cell mutation with “freezing” farther cell’s differentiation and maturation…